Biomoda, Inc.  

(Public, OTCMKTS:BMODQ)   Watch this stock  
Find more results for Biomoda, Inc
Apr 10 - Close
OTCMKTS data delayed by 15 mins - Disclaimer
Currency in USD
Range     -
52 week 0.00 - 0.01
Open     -
Vol / Avg. 0.00/398,183.00
Mkt cap 88,182.00
P/E 0.03
Div/yield     -
EPS 0.02
Shares     -
Beta 1.42
Inst. own     -

Key stats and ratios

Q3 (Sep '12) 2011
Net profit margin - -
Operating margin - -
EBITD margin - -
Return on average assets -483.88% -68.70%
Return on average equity - -
Employees 4 -
CDP Score - -


609 Broadway NE
ALBUQUERQUE, NM 87102-2334
United States - Map
+1-505-8210875 (Phone)

Website links


Biomoda, Inc. is a development-stage company. It is an invitro diagnostics company, which develops, assays, or tests, to detect cancer. The assays are performed in clinical reference laboratories using body-fluid samples. The technology is based on a porphyrin molecule that has an affinity to bind with cancer cells and cause them to fluoresce red under ultraviolet light. The porphyrin molecule is easy to obtain, manufacture and use. The technology works with a range of cell types. The Company is in the process of developing a range of assays for a range of cancer based on adaptations of the technology. The technology has the potential to diagnose other cancers as well.